BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10690840)

  • 1. Determination of surgeon's absorbed dose in iodine 125 and ruthenium 106 ophthalmic plaque surgery.
    Laube T; Flühs D; Kessler C; Bornfeld N
    Ophthalmology; 2000 Feb; 107(2):366-8; discussion 368-9. PubMed ID: 10690840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation dose to the surgeon during plaque brachytherapy.
    Classic KL; Furutani KM; Stafford SL; Pulido JS
    Retina; 2012 Oct; 32(9):1900-5. PubMed ID: 22487580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dosimetry of ruthenium applicators with an eye phantom and small volume thermoluminescence detectors].
    Muskalla K; Pothmann B; Alberti W; Bornfeld N; Foerster MH; Harder D; Hermann KP; Tabor P; Sack H; Wessing A
    Fortschr Ophthalmol; 1989; 86(6):655-8. PubMed ID: 2625294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry and design of radioactive eye plaques.
    Flühs D; Bambynek M; Heintz M; Indenkämpen F; Kolanoski H; Wegener D; Sauerwein W; Quast U
    Front Radiat Ther Oncol; 1997; 30():26-38. PubMed ID: 9205882
    [No Abstract]   [Full Text] [Related]  

  • 5. Dosimetry of ruthenium-106 ophthalmic applicators with thin layer thermoluminescence dosimeters - Clinical quality control.
    Krause F; Möller M; Risske F; Siebert FA
    Z Med Phys; 2020 May; 30(2):142-147. PubMed ID: 31818650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The design and the dosimetry of bi-nuclide radioactive ophthalmic applicators.
    Flühs D; Anastassiou G; Wening J; Sauerwein W; Bornfeld N
    Med Phys; 2004 Jun; 31(6):1481-8. PubMed ID: 15259651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miniature thermoluminescent detectors for dosimetry in radiotherapy.
    Bilski P; Waligórski MP; Budzanowski M; Ochab E; Olko P
    Radiat Prot Dosimetry; 2002; 101(1-4):473-6. PubMed ID: 12382794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plaque radiotherapy for retinoblastoma.
    Shields CL; Shields JA; De Potter P; Hernandez C; Brady LW
    Int Ophthalmol Clin; 1993; 33(3):107-18. PubMed ID: 8407174
    [No Abstract]   [Full Text] [Related]  

  • 9. An iodine-125 plaque for radiotherapy of the eye: manufacture and dosimetric considerations.
    Harnett AN; Thomson ES
    Br J Radiol; 1988 Sep; 61(729):835-8. PubMed ID: 3242502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The three-dimensional scintillation dosimetry method: test for a 106Ru eye plaque applicator.
    Kirov AS; Piao JZ; Mathur NK; Miller TR; Devic S; Trichter S; Zaider M; Soares CG; LoSasso T
    Phys Med Biol; 2005 Jul; 50(13):3063-81. PubMed ID: 15972981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetry and physical treatment planning for iodine eye plaque therapy.
    Alberti W; Pothmann B; Tabor P; Muskalla K; Hermann KP; Harder D
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1087-92. PubMed ID: 2022510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating patient-specific CT-based ophthalmic anatomy in modeling iodine-125 eye plaque brachytherapy dose distributions.
    Tien CJ; Astrahan MA; Kim JM; Materin M; Chen Z; Nath R; Liu W
    Brachytherapy; 2017; 16(5):1057-1064. PubMed ID: 28778599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results and implications of high-resolution surface dosimetry of ruthenium-106 eye applicators.
    Menapace R; Binder W; Chiari A
    Ophthalmologica; 1992; 204(2):93-100. PubMed ID: 1594188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation dose profile in 125I brachytherapy: an 8-year review.
    Al-Haj AN; Lobriguito AM; Lagarde CS
    Radiat Prot Dosimetry; 2004; 111(1):115-9. PubMed ID: 15367781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose measurement for medical staff with glass dosemeters and thermoluminescence dosemeters during 125I brachytherapy for prostate cancer.
    Fujii K; Ko S; Nako Y; Tonari A; Nishizawa K; Akahane K; Takayama M
    Radiat Prot Dosimetry; 2011 Mar; 144(1-4):459-63. PubMed ID: 21212076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Brachytherapy of ocular melanoma: physical and dosimetric aspects of 125I plaques].
    Bard JJ
    Bull Cancer Radiother; 1995; 82(3):295-305. PubMed ID: 8554879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monte Carlo dosimetry of the eye plaque design used at the St. Erik Eye Hospital for (125)I brachytherapy.
    Karlsson M; Nilsson J; Lundell M; Carlsson Tedgren A
    Brachytherapy; 2014; 13(6):651-6. PubMed ID: 24950821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre and post operative radiation protection in Ru-106 brachytherapy ophthalmic plaque surgery and related material shielding properties.
    Busoni S; Fedeli L; Belli G; Genovese E; Cannatà V; Gori C; Rossi F
    Phys Med; 2019 Jan; 57():245-250. PubMed ID: 30573352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidimensional dosimetry of ¹⁰⁶Ru eye plaques using EBT3 films and its impact on treatment planning.
    Heilemann G; Nesvacil N; Blaickner M; Kostiukhina N; Georg D
    Med Phys; 2015 Oct; 42(10):5798-808. PubMed ID: 26429254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric study of the 15 mm ROPES eye plaque.
    Granero D; Pérez-Calatayud J; Ballester F; Casal E; de Frutos JM
    Med Phys; 2004 Dec; 31(12):3330-6. PubMed ID: 15651616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.